Live
- ‘Dear Uma’ team gives a special b’day surprise for Telugu talent Sumaya Reddy
- Adivi Sesh joins the musical journey of ‘Honeymoon Express’
- Vikranth & Chandni Chowdary’s ‘Santhana Prapthirasthu’ gets a grand launch
- ‘Silk Saree’ set to charm audience on 24th May
- ‘Nee Dhaarey Nee Katha’ locks release date
- ‘Siddharth 40’ gets an announcement; Sri Ganesh to direct it
- Leaked video sparks speculation of tension between KJo & SRK
- Divya Khossla to showcase her versatility in the upcoming thriller flick ‘Savi’
- Nimrat Kaur fondly recollects ‘The Lunchbox’ triumph at Cannes
- Kartik Aaryan reaches Gwalior for ‘Chandu Champion’ trailer launch
Mission Madhumeha
The World Diabetes Day was observed on November 14. It was revealed that the number of diabetics in India is likely to rise to 101 million by 2030, as per the estimates of World Health Organisation (WHO).
The World Diabetes Day was observed on November 14. It was revealed that the number of diabetics in India is likely to rise to 101 million by 2030, as per the estimates of World Health Organisation (WHO). Countrywide, there are currently 70 million diabetics and another 80 million more in the pre-diabetes stage. Urban India sees the prevalence of diabetes six times more as compared to the rural zones.
In the circumstances, it is worthwhile to know the Union Government’s initiatives to reduce incidences or help diabetics tackle their ailment. Mission Madhumeha was launched on October 28, 2016 on the occasion of first National Ayurveda Day. A protocol on ‘Prevention and Control of Diabetes through Ayurveda’ was released for implementing the ‘Mission Madhumeha.’
The Madhumeha Assessment Tool (MAT) based on Ayurvedic philosophy was also developed for self-assessment with regard to possibilities of diabetes. The Ministry of AYUSH has urged all States/UTs, ayurveda pharma companies and other stake-holders to create awareness by organising public talks, seminars and exhibitions on the theme “Ayurveda for prevention and control of Diabetes” as a part of Mission Madhumeha for the entire year.
The Anti-diabetic Herbal Composition for Type-2 diabetes mellitus (NBRMAP-DB) trade name “BGR34” has been developed by CSIR, under the category of “Ayurvedic Proprietary Medicine” as per “Drugs and Cosmetics Act, 1940 (6th amendment) Rules” and has been tested for efficacy and safety in animal models. The Knowhow was transferred to AIMIL Pharmaceuticals (India) Ltd, for the manufacture and sale.
The BGR-34 has shown promising results with respect to glycemic parameters in patients without any adverse reaction. M/s AIMIL Pharmaceuticals launched NBRMAP-DB as “BGR-34” in the market on October 25, 2015.CSIR has also initiated detailed comprehensive human clinical trial at Banaras Hindu University, Institute of Medicines, Departments of Ayurveda, Varanasi (UP). BGR-34 is available at leading medical stores in all major cities of the country as well as it is available on Online Shopping sites.
